5 is the total number of securities Biomark Capital Management Co. LLC has owned. The longest Biomark Capital Management Co. LLC has owned a single stock is 12 quarters.
| Period | Weighting | Quarter | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Ticker | Name | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
| ADMA | ADMA BIOLOGICS, INC. | 12 | 12 | 5.01% | 33.50% | 99.96% | Q4 2015 | Q3 2018 | 12 |
| JUNO | JUNO THERAPEUTICS, INC. | 9 | 9 | 83.87% | 88.51% | 94.97% | Q4 2015 | Q4 2017 | 9 |
| MBVX | MABVAX THERAPEUTICS HO... | 6 | 6 | 0.02% | 0.09% | 0.19% | Q3 2016 | Q4 2017 | 6 |
| MBVX | MABVAX THERAPEUTICS HO... | 3 | 3 | 0.15% | 0.17% | 0.20% | Q4 2015 | Q2 2016 | 3 |
| MBVXQ | MABVAX THERAPEUTICS HO... | 3 | 3 | 0.04% | 0.12% | 0.20% | Q1 2018 | Q3 2018 | 3 |
Download | |||||||||
The securities at the top of the list , including ADMA BIOLOGICS, INC., JUNO THERAPEUTICS, INC., and MABVAX THERAPEUTICS HOLDINGS, INC., are the highest-conviction holdings of Biomark Capital Management Co. LLC.
The conviction is calculated by counting the number of quarters a security has been reported by Biomark Capital Management Co. LLC. The higher the number, the higher the conviction and longer the holding period.
This page lists all the securities that Biomark Capital Management Co. LLC owns currently or has owned in the past.